PPA
COLL icon

Parametric Portfolio Associates’s Collegium Pharmaceutical COLL Stock Holding History

Parametric Portfolio Associates’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$4.42M Buy
217,248
+108,549
+100% +$2.05M ﹤0.01% 1939
2021
Q4 		$2.03M Sell
108,699
-8,838
-8% -$172K ﹤0.01% 2429
2021
Q3 		$2.32M Sell
117,537
-18,541
-14% -$401K ﹤0.01% 2357
2021
Q2 		$3.22M Buy
136,078
+4,100
+3% +$94.7K ﹤0.01% 2151
2021
Q1 		$3.13M Buy
131,978
+31,054
+31% +$738K ﹤0.01% 2494
2020
Q4 		$2.02M Sell
100,924
-1,005
-1% -$19.6K ﹤0.01% 2644
2020
Q3 		$2.12M Buy
101,929
+9,818
+11% +$177K ﹤0.01% 2478
2020
Q2 		$1.61M Sell
92,111
-24,746
-21% -$484K ﹤0.01% 2632
2020
Q1 		$1.91M Sell
116,857
-3,949
-3% -$81.5K ﹤0.01% 2405
2019
Q4 		$2.49M Sell
120,806
-15,426
-11% -$257K ﹤0.01% 2557
2019
Q3 		$1.56M Sell
136,232
-1,395
-1% -$15.9K ﹤0.01% 2793
2019
Q2 		$1.81M Buy
137,627
+61,207
+80% +$819K ﹤0.01% 2730
2019
Q1 		$1.16M Sell
76,420
-25,442
-25% -$407K ﹤0.01% 2958
2018
Q4 		$1.75M Buy
101,862
+12,558
+14% +$215K ﹤0.01% 2672
2018
Q3 		$1.32M Buy
89,304
+23,854
+36% +$423K ﹤0.01% 2944
2018
Q2 		$1.56M Sell
65,450
-29,094
-31% -$715K ﹤0.01% 2828
2018
Q1 		$2.42M Buy
+94,544
New +$2.25M ﹤0.01% 2481
2017
Q1 		– Sell
-10,956
Closed -$171K – 3781
2016
Q4 		$171K Buy
+10,956
New +$182K ﹤0.01% 3623
2016
Q2 		– Sell
-17,927
Closed -$325K – 3838
2016
Q1 		$325K Buy
+17,927
New +$326K ﹤0.01% 3562

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Parametric Portfolio Associates's COLL Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Collegium Pharmaceutical (COLL) stake by 100% in Q1 2022, buying an estimated $2.05M and bringing the position to 217,248 shares worth $4.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1939.

Parametric Portfolio Associates first reported a position in COLL in Q1 2016 and has held it in 19 quarters since. 172 funds tracked by Wall St. Rank hold COLL as of Q1 2022.

  • Parametric Portfolio Associates held 217,248 shares of Collegium Pharmaceutical worth $4.42M as of Q1 2022.
  • Parametric Portfolio Associates bought 108,549 Collegium Pharmaceutical shares in Q1 2022, an estimated $2.05M.
  • Collegium Pharmaceutical made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1939 holding.
  • Parametric Portfolio Associates first reported a position in Collegium Pharmaceutical in Q1 2016 and has held it in 19 quarters since.
  • 172 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.